An open-label phase I study to evaluate the safety, tolerability and preliminary efficacy of YY001 in patients with advanced solid tumors

被引：0
|
作者：
Xue, Liqiong
Tang, Wenbo
Zhou, Huan
Liu, Mulin
Liu, Yuanyuan
Wang, Jinhua
Chen, Jianfeng
Liu, Mingyao
Guo, Ye
机构：
[1] Tongji Univ, Shanghai East Hosp, Sch Med, Shanghai, Peoples R China
[2] Tongji Univ, Shanghai East Hosp, Sch Med, Dept Oncol, Shanghai, Peoples R China
[3] Bengbu Med Univ, Affiliated Hosp 1, Bengbu, Peoples R China
[4] Shanghai Yuyao Biotech Co Ltd, Shanghai, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15104
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of TST001 in patients with locally advanced or metastatic solid tumors
    Gabrail, Nashat Y.
    Tolcher, Anthony
    Alese, Olatunji B.
    Cecchini, Michael
    Manish, Patel
    Park, Haeseong
    Berlin, Jordan
    Hamilton, Erika P.
    Huang, Yingjie
    Lu, Lingmin
    Wang, Jianming
    Shi, Michael
    Tong, Ming F.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [32] An open-label, phase I, dose escalating study evaluating safety, tolerability and pharmacokinetics of oral administration of irinotecan in adult patients with solid tumors
    Palshof, J. A.
    Kumler, I.
    Sorensen, P. G.
    Jensen, B. V.
    Nielsen, D. L.
    ANNALS OF ONCOLOGY, 2018, 29 : 142 - 142
  • [33] A Multicenter, Open-Label, Phase I/II Study of FN-1501 in Patients with Advanced Solid Tumors
    Richardson, Gary Edward
    Al-Rajabi, Raed
    Uprety, Dipesh
    Hamid, Anis
    Williamson, Stephen K.
    Baranda, Joaquina
    Mamdani, Hirva
    Lee, Ya-Li
    Li, Li
    Wang, Xingli
    Dong, Xunwei
    CANCERS, 2023, 15 (09)
  • [34] A phase 1, first-in-human, open-label study evaluating the safety, tolerability, pharmacokinetics, and efficacy of TT125-802 in patients with advanced solid tumors.
    Boni, Valentina
    Garralda, Elena
    Colombo, Ilaria
    Homicsko, Krisztian
    Brana, Irene
    Gruber, Dorothea
    Fluckiger-Mangual, Stefanie
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [35] A phase I, open-label, multicenter study of cediranib and AZD0530 in patients with advanced solid tumors
    Trarbach, T.
    Drevs, J.
    Strumberg, D.
    Gauler, T. C.
    Schneider, V.
    Eberhardt, W. E.
    Marotti, M.
    Puchalski, T. A.
    Swaisland, A. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [36] AN OPEN-LABEL PHASE I DOSE-ESCALATION CLINICAL TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETIC PROFILE AND PRELIMINARY EFFICACY OF VG161 IN PATIENTS WITH ADVANCED PRIMARY LIVER CANCER
    Shen, Yinan
    Shi, Guoming
    Liang, Xingmei
    Jin, Xinyan
    Wang, Youlei
    Wei, Guyue
    Chen, Yi
    Huang, Xiaoyong
    Lu, Jiacheng
    Xia, Huiqun
    Xiao, Miao
    Rahimian, Shah
    Zhao, Ronghua
    Li, Yuwei
    Lin, Danni
    Fang, Tian
    Chen, Wei
    Ma, Tao
    Bai, Xueli
    Liang, Tingbo
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A725 - A725
  • [37] A Multicenter, Open-Label, Phase 1 Study Evaluating the Safety and Tolerability of Pegaspargase in Combination with Gemcitabine in Advanced Metastatic Solid Tumors and Lymphoma
    Borad, Mitesh J.
    Babiker, Hani M.
    Anthony, Stephen
    Mita, Monica
    Buchbinder, Aby
    Keilani, Taha
    Grem, Jean
    CANCER INVESTIGATION, 2015, 33 (05) : 172 - 179
  • [38] An open-label phase I/IIa study to evaluate the safety and efficacy of CCS1477 as monotherapy and in combination in patients with advanced hematological malignancies
    Knurowski, Tomasz
    Searle, Emma
    Clegg, Karen
    Pegg, Neil
    West, William
    Haynes, Debbie
    Frese, Kristopher
    Somervaille, Tim C.
    CANCER RESEARCH, 2023, 83 (08)
  • [39] An open-label study to investigate the cardiac safety profile of cabazitaxel in patients with advanced solid tumors
    Pierre Maison-Blanche
    Shaker Dakhil
    Ari Baron
    Sylvie Rottey
    Fred Millard
    Gedske Daugaard
    Jean-Pascal Machiels
    William Conkright
    Sunil Sharma
    Patricia M. M. B. Soetekouw
    Jeffrey Yachnin
    Lisa Sengeløv
    Peter Van Veldhuizen
    Sanjiv S. Agarwala
    Dorothée Sémiond
    Mustapha Chadjaa
    Liji Shen
    James L. Wade
    Cancer Chemotherapy and Pharmacology, 2014, 73 : 1241 - 1252
  • [40] An open-label study to investigate the cardiac safety profile of cabazitaxel in patients with advanced solid tumors
    Maison-Blanche, Pierre
    Dakhil, Shaker
    Baron, Ari
    Rottey, Sylvie
    Millard, Fred
    Daugaard, Gedske
    Machiels, Jean-Pascal
    Conkright, William
    Sharma, Sunil
    Soetekouw, Patricia M. M. B.
    Yachnin, Jeffrey
    Sengelov, Lisa
    Van Veldhuizen, Peter
    Agarwala, Sanjiv S.
    Semiond, Dorothee
    Chadjaa, Mustapha
    Shen, Liji
    Wade, James L.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (06) : 1241 - 1252
12345